Search Results - "Staehr, M."

US-situs foundations by Mayo, Todd D, Staehr, Amy M, Sanborn, Von

“…Abstract In the United States, two states that have been at the vanguard of developing and enacting modern trust laws—New Hampshire and Wyoming—have recently…”
Get full text

Foundations in the wild west: the Wyoming Statutory Foundation Act by Chandler, Jordan S, Cone, Geoffrey, Panico, Paolo, Staehr, Amy M

“…Traditionally a civil law concept, the use of foundations as wealth management and succession planning vehicles is gaining popularity in common law…”
Get full text

Reduction of Free Fatty Acids, Safety, and Pharmacokinetics of Oral GS-9667, an A1 Adenosine Receptor Partial Agonist by Staehr, Peter M., Dhalla, Arvinder K., Zack, Julia, Wang, Xuegong, Ho, Yu L., Bingham, Justus, Belardinelli, Luiz

“…GS‐9667, a new selective, partial agonist of the A1 adenosine receptor (AR), may represent an effective therapy for Type 2 diabetes (T2DM) and dyslipidemia via…”
Get full text

Clinical Responses and Pharmacokinetics of MCARH171, a Human-Derived Bcma Targeted CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma: Final Results of a Phase I Clinical Trial by Mailankody, Sham, Ghosh, Arnab, Staehr, Mette, Purdon, Terence J, Roshal, Mikhail, Halton, Elizabeth, Diamonte, Claudia, Pineda, John, Anant, Pavan, Bernal, Yvette, Wills, Analisa, Korde, Neha, Lendvai, Nikoletta, Lesokhin, Alexander M., Hassoun, Hani, Hultcrantz, Malin, Landau, Heather J., Shah, Gunjan L., Scordo, Michael, Chung, David J., Lahoud, Oscar B, Khattar, Pallavi, Fernandez de Larrea, Carlos, Gao, Qi, Jungbluth, Achim, Park, Jae H., Curran, Kevin J., Sauter, Craig S., Palomba, Maria Lia, Senechal, Brigitte, Wang, Xiuyan, Dogan, Ahmet, Giralt, Sergio, Riviere, Isabelle, Landgren, Ola, Brentjens, Renier J., Smith, Eric L.

“…Introduction: BCMA targeted CAR T cell therapy has shown promising results in patients with relapsed/refractory multiple myeloma (MM). Herein, we report on the…”
Get full text

The Discovered Country: Wyoming’s Primacy as a Trust Situs Jurisdiction by Staehr, Amy M.

Get full text

A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial by Serruys, Patrick W, Prof, Chevalier, Bernard, MD, Dudek, Dariusz, MD, Cequier, Angel, MD, Carrié, Didier, MD, Iniguez, Andres, MD, Dominici, Marcello, MD, van der Schaaf, René J, MD, Haude, Michael, MD, Wasungu, Luc, PhD, Veldhof, Susan, RN, Peng, Lei, MSc, Staehr, Peter, MD, Grundeken, Maik J, MD, Ishibashi, Yuki, MD, Garcia-Garcia, Hector M, MD, Onuma, Yoshinobu, MD

“…Summary Background Despite rapid dissemination of an everolimus-eluting bioresorbable scaffold for treatment for coronary artery disease, no data from…”
Get full text

Reduction of Free Fatty Acids, Safety, and Pharmacokinetics of Oral GS‐9667, an A 1 Adenosine Receptor Partial Agonist by Staehr, Peter M., Dhalla, Arvinder K., Zack, Julia, Wang, Xuegong, Ho, Yu L., Bingham, Justus, Belardinelli, Luiz

Get full text

Give me a hand - The potential of mobile assistive robots in automotive logistics and assembly applications by Angerer, S., Strassmair, C., Staehr, M., Roettenbacher, M., Robertson, N. M.

“…This paper gives an outlook on the potential use of mobile assistive robots in automotive logistics and assembly applications. Motivated by the rising mass…”
Get full text

Reduction of free fatty acids, safety, and pharmacokinetics of oral GS-9667, an A(1) adenosine receptor partial agonist by Staehr, Peter M, Dhalla, Arvinder K, Zack, Julia, Wang, Xuegong, Ho, Yu L, Bingham, Justus, Belardinelli, Luiz

“…GS-9667, a new selective, partial agonist of the A(1) adenosine receptor (AR), may represent an effective therapy for Type 2 diabetes (T2DM) and dyslipidemia…”
Get full text

Vasomotor Response to Nitroglycerine Over 5 Years Follow-Up After Everolimus-Eluting Bioresorbable Scaffold Implantation by Dudek, Dariusz, MD, PhD, Rzeszutko, Łukasz, MD, PhD, Onuma, Yoshinobu, MD, PhD, Sotomi, Yohei, MD, Depukat, Rafał, Veldhof, Susan, RN, Ediebah, Divine, MS, Staehr, Peter, MD, Zasada, Wojciech, MD, PhD, Malinowski, Krzysztof P., MS, Kaluza, Grzegorz L., MD, PhD, Serruys, Patrick W., MD, PhD

“…Abstract Objectives This study investigated the vasomotor response to nitroglycerine (NTG) up to 5 years after ABSORB implantation. Background There are no…”
Get full text

Towards tailor made robot co workers based on a plug&produce framework by Barattini, P., Morand, C., Almajai, I., Robertson, N., Hopgood, J., Ferrara, P., Bonasso, M., Strassmair, C., Rottenbacher, M., Staehr, M., Neumann, R., Tornari, M., Rovetta, A., Plasch, M., Bauer, H., Capco, J., Woegerer, C., Pichler, A.

“…Current industrial robots are optimized to "economy of scale" while new business models demand customization, individualization and service-orientation. The…”
Get full text

Systemic Pharmacokinetics of Everolimus Eluted From the Absorb Bioresorbable Vascular Scaffold by Rizik, David G., MD, Cannon, Louis, MD, Stone, Gregg W., MD, Kennedy, Maureen, MN, Piard-Ruster, Karine, PhD, Staehr, Peter, MD, Ellis, Stephen G., MD, Kereiakes, Dean J., MD

“…[...]the systemic PK characteristics of everolimus after BVS deployment are predictable with dose-proportional behavior…”
Get full text

Effects of Age, Gender, Obesity, and Diabetes on the Efficacy and Safety of the Selective A2A Agonist Regadenoson Versus Adenosine in Myocardial Perfusion Imaging by Cerqueira, Manuel D., MD, FACC, Nguyen, Patricia, MD, Staehr, Peter, MD, Underwood, S. Richard, MD, FACC, Iskandrian, Ami E., MD, MACC

“…Effects of Age, Gender, Obesity, and Diabetes on the Efficacy and Safety of the Selective A2A Agonist Regadenoson Versus Adenosine in Myocardial Perfusion…”
Get full text

Cardiac arrhythmias in patients hospitalized with COVID-19: The ACOVID study by Zareini, Bochra, Rajan, Deepthi, El-Sheikh, Mohammed, Jensen, Mads Hashiba, Højbjerg Lassen, Mats Christian, Skaarup, Kristoffer, Hansen, Morten Lock, Biering-Sørensen, Tor, Jabbari, Reza, Kirk, Ole, Tfelt-Hansen, Jakob, Nielsen, Olav Wendelboe, Lindegaard, Birgitte, Tønder, Niels, Pedersen, Lars Kliesch, Ulrik, Charlotte Suppli, Ellekvist, Peter, Stæhr Jensen, Jens Ulrik, Schou, Morten, Gislason, Gunnar, Lamberts, Morten

“…[Display omitted]…”
Get full text

Tiered Structures for Family Office Operations: Integrating a Private Trust Company with a Family Office by Kambas, William J, Staehr, Amy M, Shields, Constance

“…The Private Trust Company A PTC is a fiduciary vehicle used to oversee assets within a trust structure by acting as trustee of one or more trusts for the…”
Get full text

Zum Reaktionsverhalten von 2,4-Dioxohexahydro-1,3,5-triazin by Schmidt, H., St hr, M.

Get full text